Targeting the Myeloid-Derived Suppressor Cell Compartment for Inducing Responsiveness to Immune Checkpoint Blockade Is Best Limited to Specific Subtypes of Gastric Cancers
Liudmila L. Kodach, Maikel P. Peppelenbosch
Topics & Concepts
BlockadeCancerImmune checkpointMedicineImmune systemT cellCancer researchCarcinogenesisCancer cellMyeloid-derived Suppressor CellSuppressorOncologyImmunologyInternal medicineReceptorGastric Cancer Management and OutcomesImmune cells in cancerGastrointestinal Tumor Research and Treatment